title: The Authors Reply.
authors.affiliation: Department of Nephrology and Transplantation, Centre Hospitalier Universitaire de Poitiers and Centre national de référence maladies rares: amylose AL et autres maladies à depots d'immunoglobulines monoclonales, Université de Poitiers, Poitiers, France.
authors.forename: Frank
authors.initials: F
authors.lastname: Bridoux
authors.affiliation: Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
authors.forename: Nelson
authors.initials: N
authors.lastname: Leung
authors.affiliation: Department of Hematology and Immunology, University Hospital St Louis, Paris, France.
authors.forename: Jean-Paul
authors.initials: JP
authors.lastname: Fermand
authors.affiliation: Department of Nephrology and Transplantation, Centre Hospitalier Universitaire de Poitiers and Centre national de référence maladies rares: amylose AL et autres maladies à depots d'immunoglobulines monoclonales, Université de Poitiers, Poitiers, France.
authors.forename: Guy
authors.initials: G
authors.lastname: Touchard
authors.affiliation: Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
authors.forename: Samih H
authors.initials: SH
authors.lastname: Nasr
mesh_terms: D006801:Humans; D007136:Immunoglobulins / Q000097:blood*; D007668:Kidney / Q000473:pathology*; D007674:Kidney Diseases / Q000473:pathology*; D008998:Monoclonal Gammopathy of Undetermined Significance / Q000150:complications* / Q000175:diagnosis*
chemical_list: D007136:Immunoglobulins